With a price range of €10 to €11.50 per share and the aim of raising around €250m through a share capital increase, METKA’s public offering opens tomorrow, 18 November, following approval of the prospectus by the Hellenic Capital Market Commission.
The offering will close on 20 November, when the final offer price is expected to be set, while trading in the shares on Euronext Athens is scheduled to begin on 26 November.
The offering comprises the issue of up to 25m new shares through a capital increase of up to €250m, with the existing shareholder’s pre-emption right waived, as well as the sale of up to 5m existing shares by METLEN.
An over-allotment option is also provided for, allowing the sale of up to 5m additional existing shares, bringing the total number of shares on offer to as many as 35m.
How the capital increase works
The maximum amount of the capital increase is set in euros, not in shares. METKA will raise up to €250m, and the number of new shares will depend on the final offer price. At the lower end of the range, €10, all 25m new shares will be issued; at the upper end, €11.50, around 21.74m will be sufficient.
METLEN, not METKA, will receive the proceeds from the sale of the existing shares.
Without the over-allotment option, the total value of the offering will range from €300m to €307.5m: €250m for METKA and €50m to €57.5m for METLEN. If the option is exercised in full, the total will rise to €350m to €365m, with METLEN’s share increasing to €100m to €115m. The number of shares on offer will reach 35m only at €10; at €11.50, it will be around 31.74m.
METLEN’s stake
The offering documents show that METKA currently has 100,236,000 shares, all of which are indirectly owned by METLEN.
After the capital increase, the total number of shares will rise to 125,236,000 if the price is set at €10, and to around 121.98m if it is set at €11.50.
After selling 5m existing shares, METLEN will retain 95,236,000 shares, representing between 76.05% and 78.08% of METKA’s share capital, depending on the price.
If the over-allotment option is also exercised in full, with a further 5m shares sold, METLEN’s stake will fall to 90,236,000 shares, or between 72.05% and 73.98%.
Based on the price range, METKA’s valuation before the capital increase is between around €1bn and €1.15bn. Following the €250m capital increase, its market value would range from €1.25bn to €1.40bn.
How the new capital will be used
The proceeds of the capital increase are intended mainly to fund METKA’s expansion into public-private partnerships (PPPs), concessions and infrastructure investment more broadly.
According to information released about the investment programme, the approximately €250m is expected to be allocated across two main areas:
- Up to €84m over 2026-2029 to meet existing investment commitments in PPP and concession projects, including the North Road Axis of Crete (BOAK) and student accommodation for the University of Western Macedonia.
- Up to €166m over 2027-2030 for new investments in PPPs, concessions and other infrastructure, with a focus on transport, environmental projects, water supply, irrigation and social infrastructure.
The projects to receive funding under the second category have not yet been finalised, as investment will depend on the progress of tenders and the opportunities that arise.
The company is also considering selected opportunities in the property market and in south-eastern Europe as part of its broader expansion.
METKA already has a substantial project portfolio. As of 30 June 2026, its construction contract backlog stood at around €2.1bn, while its strategy envisages greater participation in activities that generate recurring cash flows through long-term contracts.
The stock market listing is therefore intended to finance METKA’s next phase of growth, with METLEN remaining the new listed infrastructure group’s majority and controlling shareholder.